7A9H image
Deposition Date 2020-09-02
Release Date 2022-03-23
Last Version Date 2024-01-31
Entry Detail
PDB ID:
7A9H
Keywords:
Title:
Truncated 1-deoxy-D-xylulose 5-phosphate synthase (DXS) from Mycobacterium tuberculosis
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
1.85 Å
R-Value Free:
0.17
R-Value Work:
0.15
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:1-deoxy-D-xylulose-5-phosphate synthase,1-deoxy-D-xylulose-5-phosphate synthase
Gene (Uniprot):dxs
Chain IDs:A (auth: AAA), B (auth: BBB)
Chain Length:628
Number of Molecules:2
Biological Source:Mycobacterium tuberculosis H37Rv
Primary Citation
First crystal structures of 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) from Mycobacterium tuberculosis indicate a distinct mechanism of intermediate stabilization.
Sci Rep 12 7221 7221 (2022)
PMID: 35508530 DOI: 10.1038/s41598-022-11205-9

Abstact

The development of drug resistance by Mycobacterium tuberculosis and other pathogenic bacteria emphasizes the need for new antibiotics. Unlike animals, most bacteria synthesize isoprenoid precursors through the MEP pathway. 1-Deoxy-D-xylulose 5-phosphate synthase (DXPS) catalyzes the first reaction of the MEP pathway and is an attractive target for the development of new antibiotics. We report here the successful use of a loop truncation to crystallize and solve the first DXPS structures of a pathogen, namely M. tuberculosis (MtDXPS). The main difference found to other DXPS structures is in the active site where a highly coordinated water was found, showing a new mechanism for the enamine-intermediate stabilization. Unlike other DXPS structures, a "fork-like" motif could be identified in the enamine structure, using a different residue for the interaction with the cofactor, potentially leading to a decrease in the stability of the intermediate. In addition, electron density suggesting a phosphate group could be found close to the active site, provides new evidence for the D-GAP binding site. These results provide the opportunity to improve or develop new inhibitors specific for MtDXPS through structure-based drug design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures